NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

The objectives of the present study were: to establish the herpetic etiology of the postoperative vesicular facial lesions that appear after trigeminal sensory-root section; to determine by ...

The global gamma knife market is poised for substantial expansion between 2025 and 2035, driven by the growing incidence of neurological disorders and the increasing preference for non-invasive ...

For instance, in March 2025, we accelerated the anticipated timeline of our 510(k) submission to the FDA for trigeminal nerve ablation to May 2025, which leverages the OneRF ® Technology Platform and ...

Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation ...

The trigeminal nerve, the fifth cranial nerve ... can be done to replace tissue where a large lesion is present. In addition to the treatment approaches discussed above, counseling, psychological ...

2025 AAN 2025 Anticonvulsant Cuts Pain Fast in Facial Neuralgia The anticonvulsant fosphenytoin is safe and effective in quickly decreasing pain from sudden attacks of acute trigeminal neuralgia ...

and migrate to nerve tissues, where they persist in a latent stage. HSV-1 predominates in orofacial lesions and typically is found in the trigeminal ganglia, while HSV-2 is most commonly found in ...

MRI changes were evaluated by counting the number of lesions and assessing their ... Haider and colleagues grouped oculomotor, trigeminal, abducens, facial, vestibulocochlear, and vagal nerves ...

If it awakens, it can travel along the trigeminal nerve of the face and reach the first branch, the ophthalmic nerve, which runs to the eye. The virus can move to the surface and erupt in painful ...